Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine | Blood Advances | American Society of Hematology
Key Points. Ponatinib produces a coronary microangiopathy that mimics myocardial infarction and can be detected rapidly by contrast echocardiography.N-acetylcy
Mahmoud Aljurf
127d ago
Ponatinib produces a coronary microangiopathy that mimics myocardial infarction and can be detected rapidly by contrast echocardiography.
N-acetylcysteine therapy can potentially resolve ischemic complications caused by ponatinib-related microangiopathy.
0